Chin KL - Search Results

1

Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group Registry.

Chin KL, Wolfe R, Reid CM, Tonkin A, Hopper I, Brennan A, Andrianopoulos N, Duffy SJ, Clark D, Ajani A, Liew D; Melbourne Interventional Group (MIG). Chin KL, et al. Cardiovasc Drugs Ther. 2018 Feb;32(1):57-64. doi: 10.1007/s10557-018-6769-y. Cardiovasc Drugs Ther. 2018. PMID: 29349644

2

The cost-effectiveness of radial access percutaneous coronary intervention: A propensity-score matched analysis of Victorian data.

Lee P, Brennan A, Dinh D, Stub D, Lefkovits J, Reid CM, Zomer E, Chin K, Liew D. Lee P, et al. Clin Cardiol. 2022 Apr;45(4):435-446. doi: 10.1002/clc.23798. Epub 2022 Feb 22. Clin Cardiol. 2022. PMID: 35191069 Free PMC article.

3

Mind the Gap: Mismatches Between Clinicians and Patients in Heart Failure Medication Management.

Chin KL, Skiba M, Reid CM, Tonkin A, Hopper I, Mariani JA, Liew D. Chin KL, et al. Cardiovasc Drugs Ther. 2018 Feb;32(1):37-46. doi: 10.1007/s10557-017-6768-4. Cardiovasc Drugs Ther. 2018. PMID: 29318439

4

Temporal Changes in Characteristics, Treatment and Outcomes of Heart Failure Patients Undergoing Percutaneous Coronary Intervention Findings From Melbourne Interventional Group Registry.

Chin KL, Tacey M, Reid CM, Tonkin A, Hopper I, Brennan A, Andrianopoulos N, Duffy SJ, Clark D, Ajani AE, Liew D; Melbourne Interventional Group (MIG). Chin KL, et al. Heart Lung Circ. 2019 Jul;28(7):1018-1026. doi: 10.1016/j.hlc.2018.03.030. Epub 2018 Jun 8. Heart Lung Circ. 2019. PMID: 29960835

5

Comorbidities in Heart Failure: Are There Gender Differences?

Hopper I, Kotecha D, Chin KL, Mentz RJ, von Lueder TG. Hopper I, et al. Among authors: chin kl. Curr Heart Fail Rep. 2016 Feb;13(1):1-12. doi: 10.1007/s11897-016-0280-1. Curr Heart Fail Rep. 2016. PMID: 26829930 Review.

6

The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice.

Chin KL, Skiba M, Tonkin A, Reid CM, Liew D, Krum H, Hopper I. Chin KL, et al. Heart Fail Rev. 2016 Nov;21(6):675-697. doi: 10.1007/s10741-016-9575-2. Heart Fail Rev. 2016. PMID: 27465132 Review.

7

Risk Prediction Models for Incident Heart Failure: A Systematic Review of Methodology and Model Performance.

Sahle BW, Owen AJ, Chin KL, Reid CM. Sahle BW, et al. Among authors: chin kl. J Card Fail. 2017 Sep;23(9):680-687. doi: 10.1016/j.cardfail.2017.03.005. Epub 2017 Mar 21. J Card Fail. 2017. PMID: 28336380 Review.

8

Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies.

Chin KL, Ofori-Asenso R, Hopper I, von Lueder TG, Reid CM, Zoungas S, Wang BH, Liew D. Chin KL, et al. Cardiovasc Res. 2019 Feb 1;115(2):266-276. doi: 10.1093/cvr/cvy295. Cardiovasc Res. 2019. PMID: 30475996

9

Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate.

Chin KL, Collier T, Pocock S, Pitt B, McMurray JJV, van Veldhuisen DJ, Swedberg K, Vincent J, Zannad F, Liew D. Chin KL, et al. Clin Res Cardiol. 2019 Jul;108(7):806-814. doi: 10.1007/s00392-018-1410-4. Epub 2019 Jan 2. Clin Res Cardiol. 2019. PMID: 30604047 Clinical Trial.

10

Cost-Effectiveness of Switching Patients With Heart Failure and Reduced Ejection Fraction to Sacubitril/Valsartan: The Australian Perspective.

Chin KL, Zomer E, Wang BH, Liew D. Chin KL, et al. Heart Lung Circ. 2020 Sep;29(9):1310-1317. doi: 10.1016/j.hlc.2019.03.007. Epub 2019 Apr 2. Heart Lung Circ. 2020. PMID: 32303468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters